Advertisement

Physical Activity During Daily Life and Circulating Biomarker Levels in Patients With Peripheral Arterial Disease

Published:September 09, 2008DOI:https://doi.org/10.1016/j.amjcard.2008.06.051
      Higher levels of inflammation are associated with adverse outcomes in patients with lower extremity peripheral arterial disease (PAD). This study evaluated associations of physical activity during daily life with levels of inflammatory biomarkers, D-dimer, and homocysteine in patients with PAD. Participants were 244 men and women (mean age 74.4 ± 8.2 years) with PAD (ankle brachial index <0.90). C-reactive protein, interleukin-6, soluble intracellular adhesion molecule-1, soluble vascular cellular adhesion molecule-1, D-dimer, and homocysteine were assessed at study entry. Physical activity was objectively assessed with a vertical accelerometer, which participants wore continuously for 7 days. After adjusting for age, gender, race, body mass index, smoking, co-morbidities, ankle brachial index, and other potential confounders, higher physical activity levels were associated linearly and significantly with lower levels of all measured circulating biomarkers: soluble vascular cellular adhesion molecule-1 (p trend = 0.001), D-dimer (p trend = 0.005), homocysteine (p trend = 0.006), interleukin-6 (p trend = 0.010), C-reactive protein (p trend = 0.028), and soluble intracellular adhesion molecule-1 (p trend = 0.033). In conclusion, higher levels of physical activity were associated independently with lower levels of inflammatory markers, homocysteine, and D-dimer in patients with PAD.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Beckman J.A.
        • Preis O.
        • Ridker P.M.
        • Gerhard-Herman M.
        Comparison of usefulness of inflammatory markers in patients with versus without peripheral arterial disease in predicting adverse cardiovascular outcomes (myocardial infarction, stroke, and death).
        Am J Cardiol. 2005; 96: 1374-1378
        • Goessens B.M.B.
        • vanderGraaf Y.
        • Olijhoek J.K.
        • Visseren S.L.
        The course of vascular risk factors and the occurrence of vascular events in patients with symptomatic peripheral arterial disease.
        J Vasc Surg. 2007; 45: 47-54
        • Musicant S.E.
        • Taylor L.M.
        • Peters D.
        • Schuff R.A.
        • Urankar R.
        • Landry G.J.
        • Moneta G.L.
        Prospective evaluation of the relationship between C-reactive protein, D-dimer and progression of peripheral arterial disease.
        J Vasc Surg. 2006; 43: 772-780
        • Schillinger M.
        • Exner M.
        • Miekusch
        • Rumpold H.
        • Ahmadi R.
        • Sabeti S.
        • Haumer M.
        • Wagner O.
        • Minar E.
        Vascular inflammation and percutaneous transluminal angioplasty of the femoropopliteal artery: association with restenosis.
        Radiology. 2002; 225: 21-26
        • Tschopl M.
        • Tsakiris D.A.
        • Marbet G.A.
        • Labs K.H.
        • Jager K.
        Role of hemostatic risk factors for restenosis in peripheral arterial occlusive disease after transluminal angioplasty.
        Arterioscler Thromb Vasc Biol. 1997; 17: 3208-3214
        • Schillinger M.
        • Haumer M.
        • Schlerka G.
        • Mlekusch W.
        • Exner M.
        • Ahmadi R.
        • Minar E.
        Restenosis after percutaneous transluminal angioplasty in the femoropopliteal segment: the role of inflammation.
        J Endovasc Ther. 2001; 8: 477-483
        • Schillinger M.
        • Exner M.
        • Mlekusch W.
        • Haumer M.
        • Rumpold H.
        • Ahmadi R.
        • Sabeti S.
        • Wagner O.
        • Minar E.
        Endovascular revascularization below the knee: 6-month results and the predictive value of C-reactive protein level.
        Radiology. 2003; 227: 419-425
        • Turton E.P.L.
        • Coughlin P.A.
        • Kester R.C.
        • Scott D.J.
        Exercise training reduces the acute inflammatory response associated with claudication.
        Eur J Vasc Endovasc Surg. 2002; 23: 309-316
        • McDermott M.M.
        • Greenland P.
        • Liu K.
        • Guralnik J.M.
        • Celic L.
        • Criqui M.H.
        • Chan C.
        • Martin G.J.
        • Schneider J.
        • Pearce W.H.
        • Taylor L.M.
        • Clark E.
        The ankle brachial index as a measure of leg functioning and physical activity in peripheral arterial disease: the Walking And Leg Circulation Study.
        Ann Intern Med. 2002; 136: 873-883
        • McDermott M.M.
        • Liu K.
        • Greenland P.
        • Guralnik J.M.
        • Criqui M.H.
        • Chan C.
        • Pearce W.H.
        • Schneider J.R.
        • Ferrucci L.
        • Celic L.
        • et al.
        Functional decline in peripheral arterial disease: Associations with the ankle brachial index and leg symptoms.
        JAMA. 2004; 292: 453-461
        • McDermott M.M.
        • Ohlmiller S.M.
        • Liu K.
        • Guralnik J.M.
        • Martin G.J.
        • Pearce W.H.
        • Greenland P.
        Gait alterations associated with walking impairment in people with peripheral arterial disease with and without intermittent claudication.
        J Am Geriatr Soc. 2001; 49: 747-754
        • Shadman R.
        • Criqui M.H.
        • Bundens W.P.
        • Fronek A.
        • Denenberg J.O.
        • Gamst A.C.
        • McDermott M.M.
        Subclavian artery stenosis: prevalence, risk factors, and association with cardiovascular disease.
        J Am Coll Cardiol. 2004; 44: 618-623
        • Hiatt W.R.
        • Hoag S.
        • Hamman R.F.
        Effect of diagnostic criteria on the prevalence of peripheral arterial disease.
        Circulation. 1995; 91: 1472-1479
        • Allain C.C.
        • Poon L.S.
        • Chan C.S.G.
        • Richard W.
        • Fu P.C.
        Enzymatic determination of total serum cholesterol.
        Clin Chem. 1974; 20: 470-475
        • Sugiuchi H.
        • Ugi Y.
        • Okabe H.
        • Irie T.
        • Uekama K.
        • Kayahara N.
        • Miyauchi K.
        Direct measurement of high-density lipoprotein cholesterol in serum with polyethylene glycol-modified enzymes and sulfated a-cyclodextrin.
        Clin Chem. 1995; 41: 717-723
        • Guralnik J.M.
        • Fried L.P.
        • Simonsick E.M.
        The Women's Health and Aging Study: Health and Social Characteristics of Older Women With Disability.
        National Institute on Aging, Bethesda, MD1995
        • McDermott M.M.
        • Guralnik J.M.
        • Albay M.
        • Bandinelli S.
        • Miniati B.
        • Ferrucci L.
        Impairments of muscles and nerves associated with peripheral arterial disease and their relationship with lower extremity functioning: The InCHIANTI Study.
        J Am Geriatr Soc. 2004; 52: 405-410
        • Mitsiopoulos N.
        • Baumgartner R.N.
        • Heymsfield S.B.
        • Lyons W.
        • Gallagher D.
        • Ross R.
        Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography.
        J Appl Physiol. 1998; 86: 1097-1098
        • Criqui M.H.
        • Denenberg J.O.
        • Bird C.E.
        • Fronek A.
        • Klauber M.R.
        • Langer R.D.
        The correlation between symptoms and non-invasive test results in patients referred for peripheral arterial disease testing.
        Vasc Med. 1996; 1: 65-71
        • McDermott M.M.
        • Hoff F.
        • Ferrucci L.
        • Pearce W.H.
        • Guralnik J.M.
        • Tian L.
        • Liu K.
        • Schneider J.R.
        • Scharma L.
        • Tan J.
        • Criqui M.H.
        Lower extremity ischemia, calf skeletal muscle characteristics, and functional impairment in peripheral arterial disease.
        J Am Geriatr Soc. 2007; 55: 400-406
        • Criqui M.H.
        • Langer R.D.
        • Fronek A.
        • Feigelson H.S.
        • Klauber M.R.
        • McCann T.J.
        • Browner D.
        Mortality over a period of 10 years in patients with peripheral arterial disease.
        N Engl J Med. 1992; 326: 381-386
        • Newman A.B.
        • Sutton-Tyrrell K.
        • Vogt M.T.
        • Kuller L.H.
        Morbidity and mortality in hypertensive adults with a low ankle/arm blood pressure index.
        JAMA. 1993; 270: 487-489
        • Garg P.K.
        • Tian L.
        • Criqui M.H.
        • Liu K.
        • Ferrucci L.
        • Guralnik J.M.
        • Tan J.
        • McDermott M.M.
        Physical activity during daily life and mortality in patients with peripheral arterial disease.
        Circulation. 2006; 114: 242-248
        • McDermott M.M.
        • Feruccii L.
        • Guralnik J.M.
        • Tian L.
        • Green D.
        • Liu K.
        • Tan J.
        • Laio Y.
        • Pearce W.H.
        • Schneider J.R.
        • et al.
        Elevated levels of inflammation, D-dimer, and homocysteine are associated with adverse calf muscle characteristics and reduced calf strength in peripheral arterial disease.
        J Am Coll Cardiol. 2007; 50: 897-905